"Boldness be my friend" (Shakespeare; Cymbeline)

Jessica K. Altman; Martin S. Tallman

doi:10.1182/blood-2011-11-386557

"Boldness be my friend" (Shakespeare; Cymbeline)

Jessica K. Altman^*, Martin S. Tallman

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

Au et al. report in this issue of Blood that oral arsenic trioxide (ATO) may be safely used in maintenance therapy in acute promyelocytic leukemia (APL).¹ This is a major improvement in convenience given that intravenous (IV) ATO requires daily administration for weeks at a time. In addition, the oral formulation may be less toxic. The time seems right to carefully explore the introduction of oral ATO earlier in treatment of the disease.

Original language	English (US)
Pages (from-to)	6477-6478
Number of pages	2
Journal	Blood
Volume	118
Issue number	25
DOIs	https://doi.org/10.1182/blood-2011-11-386557
State	Published - Dec 15 2011

ASJC Scopus subject areas

Hematology
Biochemistry
Cell Biology
Immunology

Access to Document

10.1182/blood-2011-11-386557

Cite this

@article{26c4cf55c5b84302a17ab9c15301029d,

title = "{"}Boldness be my friend{"} (Shakespeare; Cymbeline)",

abstract = "Au et al. report in this issue of Blood that oral arsenic trioxide (ATO) may be safely used in maintenance therapy in acute promyelocytic leukemia (APL).1 This is a major improvement in convenience given that intravenous (IV) ATO requires daily administration for weeks at a time. In addition, the oral formulation may be less toxic. The time seems right to carefully explore the introduction of oral ATO earlier in treatment of the disease.",

author = "Altman, {Jessica K.} and Tallman, {Martin S.}",

year = "2011",

month = dec,

day = "15",

doi = "10.1182/blood-2011-11-386557",

language = "English (US)",

volume = "118",

pages = "6477--6478",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "25",

}

TY - JOUR

T1 - "Boldness be my friend" (Shakespeare; Cymbeline)

AU - Altman, Jessica K.

AU - Tallman, Martin S.

PY - 2011/12/15

Y1 - 2011/12/15

N2 - Au et al. report in this issue of Blood that oral arsenic trioxide (ATO) may be safely used in maintenance therapy in acute promyelocytic leukemia (APL).1 This is a major improvement in convenience given that intravenous (IV) ATO requires daily administration for weeks at a time. In addition, the oral formulation may be less toxic. The time seems right to carefully explore the introduction of oral ATO earlier in treatment of the disease.

AB - Au et al. report in this issue of Blood that oral arsenic trioxide (ATO) may be safely used in maintenance therapy in acute promyelocytic leukemia (APL).1 This is a major improvement in convenience given that intravenous (IV) ATO requires daily administration for weeks at a time. In addition, the oral formulation may be less toxic. The time seems right to carefully explore the introduction of oral ATO earlier in treatment of the disease.

UR - http://www.scopus.com/inward/record.url?scp=84055213205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84055213205&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-11-386557

DO - 10.1182/blood-2011-11-386557

M3 - Comment/debate

C2 - 22174303

AN - SCOPUS:84055213205

SN - 0006-4971

VL - 118

SP - 6477

EP - 6478

JO - Blood

JF - Blood

IS - 25

ER -

"Boldness be my friend" (Shakespeare; Cymbeline)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this